PHARMACEUTICAL group Elan has announced that its subsidiary, Athena Neurosciences, has reached agreement with US company Pharmavene to license the worldwide rights to the anti-epileptic medication, Carbatrol.
Elan drug agreement
PHARMACEUTICAL group Elan has announced that its subsidiary, Athena Neurosciences, has reached agreement with US company Pharmavene…
Join The Irish Times on WhatsApp and stay up to date
Sign up to the Business Today newsletter for the latest new and commentary in your inbox
Listen to Inside Business podcast for a look at business and economics from an Irish perspective







